According to the Zhitong Finance App, Cinda Biotech (01801.HK) issued an announcement regarding the global strategic cooperation between Cinda Biotech and Takeda Pharmaceuticals (through Takeda Pharmaceuticals International AG, a wholly-owned subsidiary of Takeda Pharmaceuticals), and that all prerequisites for each licensing, option and cooperation agreement and share issuance agreement have been reached or exempted (if applicable). As a result, the licensing, option and cooperation agreement was completed, and the share issuance agreement was completed on December 4, 2025.

Zhitongcaijing · 1d ago
According to the Zhitong Finance App, Cinda Biotech (01801.HK) issued an announcement regarding the global strategic cooperation between Cinda Biotech and Takeda Pharmaceuticals (through Takeda Pharmaceuticals International AG, a wholly-owned subsidiary of Takeda Pharmaceuticals), and that all prerequisites for each licensing, option and cooperation agreement and share issuance agreement have been reached or exempted (if applicable). As a result, the licensing, option and cooperation agreement was completed, and the share issuance agreement was completed on December 4, 2025.